In the animal model of AD, cognitive deficits are often accompanied by the formation of Aβ plaques, which deactivates the cAMP/cGMP pathway by decreasing the phosphorylation of CREB and BDNF expression (Xu et al., 2006). Here, CREB1 is linked to Alzheimer disease.